JP2023522213A5 - - Google Patents

Info

Publication number
JP2023522213A5
JP2023522213A5 JP2022563025A JP2022563025A JP2023522213A5 JP 2023522213 A5 JP2023522213 A5 JP 2023522213A5 JP 2022563025 A JP2022563025 A JP 2022563025A JP 2022563025 A JP2022563025 A JP 2022563025A JP 2023522213 A5 JP2023522213 A5 JP 2023522213A5
Authority
JP
Japan
Prior art keywords
disease
cell
cells
syndrome
inflammatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022563025A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023522213A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/027674 external-priority patent/WO2021211961A1/en
Publication of JP2023522213A publication Critical patent/JP2023522213A/ja
Publication of JP2023522213A5 publication Critical patent/JP2023522213A5/ja
Pending legal-status Critical Current

Links

JP2022563025A 2020-04-17 2021-04-16 再生非ステロイド性抗炎症組成物、その生産方法、及び使用方法 Pending JP2023522213A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063011373P 2020-04-17 2020-04-17
US63/011,373 2020-04-17
PCT/US2021/027674 WO2021211961A1 (en) 2020-04-17 2021-04-16 Regenerative nonsteroidal anti-inflammatory compositions, methods of production, and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2023522213A JP2023522213A (ja) 2023-05-29
JP2023522213A5 true JP2023522213A5 (enExample) 2024-04-22

Family

ID=78084637

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022563025A Pending JP2023522213A (ja) 2020-04-17 2021-04-16 再生非ステロイド性抗炎症組成物、その生産方法、及び使用方法

Country Status (6)

Country Link
US (1) US20230190821A1 (enExample)
EP (1) EP4135729A4 (enExample)
JP (1) JP2023522213A (enExample)
AU (1) AU2021257255A1 (enExample)
CA (1) CA3175599A1 (enExample)
WO (1) WO2021211961A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240189364A1 (en) * 2021-02-26 2024-06-13 Arugula Sciences Llc Villi stromal cells compositions and uses thereof
JP2024544108A (ja) * 2021-12-24 2024-11-28 イーエイチジェイ アイピー リミテッド 胎盤組成物
CN116626303B (zh) * 2023-03-17 2026-04-14 重庆医科大学 槲皮素经scap/srebp2/nlrp3通路减轻脂多糖急性肺损伤的动物模型研究方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101569168B1 (ko) * 2007-02-12 2015-11-13 안트로제네시스 코포레이션 태반 줄기세포를 이용한 염증 질환의 치료
US20150010609A1 (en) * 2010-02-18 2015-01-08 Osiris Therapeutics, Inc. Immunocompatible chorionic membrane products
SG11201609254YA (en) * 2014-05-07 2016-12-29 Osiris Therapeutics Inc Therapeutic placental compositions, methods of making and methods of use
US20180280444A1 (en) * 2016-06-10 2018-10-04 Batu Biologics, Inc. Nanoparticle based tumor endothelial targeting vaccine
EP3707515A1 (en) * 2017-11-06 2020-09-16 Kings College London Therapeutic substances, their preparation and diagnostic procedure
US20200397990A1 (en) * 2018-02-28 2020-12-24 Regents Of The University Of Minnesota Multi-compartment syringe with pump mechanism
WO2019169141A1 (en) * 2018-02-28 2019-09-06 Lester Smith Medical Research Institute Production and use of extracellular vesicles
CA3140452A1 (en) * 2018-06-11 2019-12-19 Angelita De Francisco Extracellular vesicles derived from mesenchymal stem cells

Similar Documents

Publication Publication Date Title
JP6483187B2 (ja) 増強された幹細胞組成物
US9833482B2 (en) Mammalian fetal pulmonary cells and therapeutic use of same
JP2024163978A (ja) 間葉系間質細胞エキソソーム処置単球およびそれらの使用
US11285174B2 (en) Macrophage-based therapy for use in the treatment of liver injury
Wan et al. Update on therapeutic mechanism for bone marrow stromal cells in ischemic stroke
US20140134140A1 (en) Mesenchymal stem cell compositions for the treatment of microbial infections
RU2710543C2 (ru) Композиции для лечения поражений головного мозга
CN110665010A (zh) 用于脂肪肝及脂质代谢紊乱治疗的核酸药物及其制备方法
US20230190821A1 (en) Regenerative nonsteroidal anti-inflammatory compositions, methods of production, and methods of use thereof
Sato et al. Reduction of Brain Injury in Neonatal Hypoxic—Ischemic Rats by Intracerebroventricular Injection of Neural Stem/Progenitor Cells Together With Chondroitinase ABC
JP2022512658A5 (enExample)
Conklin et al. Intravenous mesenchymal stromal cell therapy for inflammatory bowel disease: Lessons from the acute graft versus host disease experience
WO2021226455A1 (en) Methods and compositions for reducing joint inflammation using mesenchymal stem cells
WO2014089397A1 (en) Compositions and methods of treating and preventing pulmonary fibrosis
Zhang et al. Adipose-derived mesenchymal stem cells suppress of acute rejection in small bowel transplantation
JP2025540166A (ja) 化合物、及びTreg関連疾患の治療におけるその使用
WO2023119239A1 (en) Method of treating severe graft versus host disease
JP2022513490A5 (enExample)
KR20200127039A (ko) 다능성 간세포에 의한 주산기 뇌장애의 개선 및 치료
US20240226173A1 (en) Methods and compositions for treating liver disease
CN112074282A (zh) 脊髓损伤的治疗剂
US20240238301A1 (en) Compositions and methods for reduced toxicity in transplantation using janus kinase (jak) inhibitors
Schwaiger et al. Dipeptidyl peptidase IV (DPPIV/CD26) inhibition does not improve engraftment of unfractionated syngeneic or allogeneic bone marrow after nonmyeloablative conditioning
CN103923208B (zh) 一种重组人角质细胞生长因子-2突变体的活性稳定剂
CN112656789A (zh) Ficz在抑制肿瘤细胞迁移中的应用